Sensus (SRTS) - Cash per Single Share

Sensus Healthcare, Inc. (SRTS) dominates the non-invasive skin cancer treatment segment thanks to unique patents. Regular system maintenance and the sale of components ensure a steady stream of profit. The narrow business profile is offset by stable service payments. The cash per share figure helps identify the asset's undervaluation, while the value of 0.78 expresses the metric level.
Comprehensive metric breakdowns and analytics for Sensus (SRTS)

Sensus Healthcare, Inc. (SRTS) generates revenue through the sale of superficial radiation therapy systems for the treatment of skin cancer. The trend of highly liquid assets per share reflects the monetization efficiency of these sales. This metric is calculated by dividing the total cash fund by the number of issued securities. It measures the actual capital value available to the shareholder upon liquidation. A stable cash balance ensures the company's financial stability regardless of market revaluation.